• Biotech R&D spending by country 2018

This statistic shows the research and development spending of biotechnology companies based in selected countries for 2018 (or latest year available - 2017). During that year, biotechnology companies in Germany spent over 1.57 billion U.S. dollars on research and development.

Biotech research and development expenditure in selected countries in 2018* (in million U.S. dollars)

Characteristic	R&D spending in million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Source

Show detailed source information?

Already a member?

Source

Release date

October 2020

More information

Region

Worldwide, OECD

Survey time period

2018

Supplementary notes

* Biotechnology R&D expenditures in the business sector, 2018 or latest available year (2017).
For Canada, this includes medical biotechnology, environmental biotechnology, industrial biotechnology and agricultural biotechnology.
For the Russian Federation, a proxy indicator is used: R&D expenditure in Life Sciences (before 2011 - Living Systems), which include bioengineering, biocatalysis, biosynthesis and biosensor technologies, biomedical and veterinary technologies, genomics and pharmaco-genetics, living cell technologies.
For Germany, 2017 BERD was uses as 2018 BERD was not available.
For the United States, firms with 5 or more employees only.
For Latvia, this includes medical biotechnology, environmental biotechnology, industrial biotechnology and agricultural biotechnology.
For the United States, prior to 2017 statistics are based on companies in the United States that reported to the survey and had 5 or more employees (i.e., these statistics do not include an adjustment to the weight to account for unit nonresponse). Beginning in 2017, the survey includes companies with 10 or more employees (companies with fewer than 10 employees are included in a separate survey, the Annual Business Survey). Beginning in 2018, weights are adjusted to account for unit nonresponse and statistics are for companies that performed or funded $50,000 or more of R&D.